Biotech News
TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
ir.telabio.com2026-05-06 15:03 EST
MALVERN, Pa., Feb. 20, 2026 (GLOBE NEWSWIRE) -- TELA Bio, Inc. ("TELA Bio") (NASDAQ: TELA), a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions, today announced that the Compensation Committee of the Board of Directors of TELA Bio